Biothera Develops New Method For Analyzing Beta Glucan Structure

Main Category: Immune System / Vaccines
Also Included In: Pharmacy / Pharmacist;  Pharma Industry / Biotech Industry
Article Date: 06 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:4 and a half stars

4.5 (2 votes)


Biothera has developed a new analytical method to characterize a key structural attribute of beta 1,3/1,6 glucans, which will aid researchers developing this immune-enhancing carbohydrate for pharmaceutical applications.

The method was presented recently to scientists at both the International Carbohydrate Symposium in Oslo, Norway, and the American Chemical Society national meeting in Philadelphia.

Beta 1,3 glucans are polysaccharides known for their ability to enhance innate immune responses. Derived from the cell walls of yeast and fungi, beta glucans can vary in terms of molecular weight, frequency of side chain branching, and the length and composition of side chains. These structural variations may affect bioactivity.

"We believe our on-going analytical chemistry program will become the new gold standard for structural characterization of beta glucan," said Daniel Conners, Biothera chairman and founder. "It is critical to fully characterize these compounds to further our understanding of their bioactivity and, ultimately, enable the development of pharmaceuticals."

The Biothera method, which employs alkaline degradation, analyzes the length, distribution and composition of side chains that contribute to beta glucan's potency as an immune modulator. The presentation in Norway was entitled, "Analysis of Side Chain Lengths of Branched β-1,3-Glucans by Alkaline Degradation."

"The new assay reflects Biothera's position as a world leader in carbohydrate chemistry," said Mr. Conners. "We are committed to pioneering beta glucan technology."

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Biothera also manufactures and markets food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets.

Biothera

Article adapted by Medical News Today from original press release.
Visit our immune system / vaccines section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Biothera. "Biothera Develops New Method For Analyzing Beta Glucan Structure." Medical News Today. MediLexicon, Intl., 6 Oct. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/124294.php>

APA
Biothera. (2008, October 6). "Biothera Develops New Method For Analyzing Beta Glucan Structure." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/124294.php.

Please note: If no author information is provided, the source is cited instead.


Immune System / Vaccines

Most Popular Articles



Follow Our Immune System News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Immune System / Vaccines Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »